144 related articles for article (PubMed ID: 21921049)
1. Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
Blood; 2011 Nov; 118(19):5211-7. PubMed ID: 21921049
[TBL] [Abstract][Full Text] [Related]
2. HLA associations in classical Hodgkin lymphoma: EBV status matters.
Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
PLoS One; 2012; 7(7):e39986. PubMed ID: 22808081
[TBL] [Abstract][Full Text] [Related]
3. HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China.
Huang X; Hepkema B; Nolte I; Kushekhar K; Jongsma T; Veenstra R; Poppema S; Gao Z; Visser L; Diepstra A; van den Berg A
PLoS One; 2012; 7(2):e31865. PubMed ID: 22355400
[TBL] [Abstract][Full Text] [Related]
4. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
[TBL] [Abstract][Full Text] [Related]
5. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
[TBL] [Abstract][Full Text] [Related]
6. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
[TBL] [Abstract][Full Text] [Related]
7. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.
Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadié M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjosé S; Lathrop M; Melbye M; Brennan P; Diepstra A; van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1838-43. PubMed ID: 26404960
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadié M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini RM; Adami HO; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjønneland A; Melin B; Canzian F; Khaw KT; Travis RC; Peeters PH; González CA; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjosé S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
J Natl Cancer Inst; 2012 Feb; 104(3):240-53. PubMed ID: 22286212
[TBL] [Abstract][Full Text] [Related]
9. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
11. Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.
Jiang P; Nolte IM; Hepkema BG; Stulp M; van den Berg A; Diepstra A
Front Immunol; 2022; 13():829943. PubMed ID: 35154153
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients.
Huang X; van den Berg A; Gao Z; Visser L; Nolte I; Vos H; Hepkema B; Kooistra W; Poppema S; Diepstra A
PLoS One; 2010 May; 5(5):e10865. PubMed ID: 20526359
[TBL] [Abstract][Full Text] [Related]
13. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
[TBL] [Abstract][Full Text] [Related]
14. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
15. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
[TBL] [Abstract][Full Text] [Related]
16. HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.
Jones K; Wockner L; Thornton A; Gottlieb D; Ritchie DS; Seymour JF; Kumarasinghe G; Gandhi MK
Transpl Immunol; 2015 Mar; 32(2):126-30. PubMed ID: 25731678
[TBL] [Abstract][Full Text] [Related]
17. Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.
Martin P; Martínez-Velasquez J; Coronado MJ; Krsnik I; Provencio M; Navarro B; Moraru M; Bellas C; Vilches C; Gomez-Lozano N
Leuk Lymphoma; 2017 Feb; 58(2):438-444. PubMed ID: 27267403
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
19. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
[TBL] [Abstract][Full Text] [Related]
20. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
